Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
- DOI
- 10.1007/s00408-021-00437-7
- Published
- 2021-04
- Container
- Lung
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00408-021-00437-7,
title = {Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant},
author = {Alyn H. Morice and Surinder S. Birring and Jaclyn A. Smith and Lorcan P. McGarvey and Jonathan Schelfhout and Allison Martin Nguyen and Zhi Jin Xu and Wen-Chi Wu and David R. Muccino and Mandel R. Sher},
year = {2021},
journal = {Lung},
doi = {10.1007/s00408-021-00437-7},
url = {https://doi.org/10.1007/s00408-021-00437-7}
}RIS
TY - JOUR TI - Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant AU - Alyn H. Morice AU - Surinder S. Birring AU - Jaclyn A. Smith AU - Lorcan P. McGarvey AU - Jonathan Schelfhout AU - Allison Martin Nguyen AU - Zhi Jin Xu AU - Wen-Chi Wu AU - David R. Muccino AU - Mandel R. Sher PY - 2021 JO - Lung DO - 10.1007/s00408-021-00437-7 UR - https://doi.org/10.1007/s00408-021-00437-7 ER -
APA
Morice, A. H., Birring, S. S., Smith, J. A., McGarvey, L. P., Schelfhout, J., Nguyen, A. M., Xu, Z. J., Wu, W., Muccino, D. R., & Sher, M. R. (2021). Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant. Lung. https://doi.org/10.1007/s00408-021-00437-7
Source records
- crossref · retrieved 2026-09-27T06:59:20.741Z